The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
ColumnsFull Access

Datapoints: False Starts in Psychotherapy for Substance Use Disorders and PTSD in the VHA

Published Online:https://doi.org/10.1176/appi.ps.201300145

As part of the push toward evidence-based mental health treatment, there is interest in increasing the proportion of patients who engage in evidence-based psychotherapy. However, attrition is a common phenomenon, especially at the beginning of psychotherapy. Using Veterans Health Administration (VHA) data, we examined psychotherapy utilization patterns among patients diagnosed as having a substance use disorder or posttraumatic stress disorder (PTSD) in fiscal year (FY) 2008. Start of a psychotherapy treatment episode was defined as the first psychotherapy visit after 60 days with no VHA psychotherapy visits within VHA. Thus psychotherapy visits more than 60 days apart were viewed as separate treatment episodes. This is consistent with a widely used definition of a treatment episode for a substance use disorder (1). Among patients who initiated psychotherapy, we also examined attrition—defined as attending only one or two psychotherapy visits.

In FY 2008, of the 380,231 patients with an inpatient or outpatient encounter that included a substance use disorder diagnosis, 210,168 (55%) had at least one outpatient psychotherapy episode start, and among those, 121,257 (58%) attended only one or two visits. Of the 442,359 patients with an inpatient or outpatient encounter in FY 2008 that included a PTSD diagnosis, 297,831 (67%) had at least one outpatient psychotherapy episode start, and, among those, 183,801 (62%) attended only one or two visits (Figure 1). Repeated attempts at psychotherapy engagement were not rare; 40% of those with a substance use disorder and 48% of those with PTSD who started one outpatient psychotherapy episode had at least one additional episode start in the same year.

Figure 1 Percentage of patients with posttraumatic stress disorder (PTSD) or a substance use disorder in fiscal year 2008, by number of psychotherapy visits and by episode of care

These observations may have significant clinical and measurement implications. Clinically, these results suggest that more needs to be done to encourage patients to initiate and engage in treatment. Although attrition from care is common, both clinicians and patients should be aware that a significant number of patients who initially disengage from care will later make attempts at reengagement. Efforts to reengage patients may improve engagement rates and mental health outcomes. Explaining these rates to patients may reduce discouragement and self-stigma among those having difficulty with adherence during attempts at treatment seeking. Moreover, many patients with PTSD or a substance use disorder may need more than one attempt at psychotherapy to be successful.

Some widely used measures of treatment engagement examine only the first episode of care in a year (1). Our results suggest that this approach could underestimate the proportion of patients who engage in treatment during a year because it overlooks subsequent treatment episodes. Our results underscore the importance of the adage, “If at first you don’t succeed, try, try again.”

The authors are with the Program Evaluation and Resource Center, U.S. Department of Veterans Affairs Palo Alto Health Care System, 795 Willow Rd. (152 MPD), Menlo Park, CA 94025 (e-mail: ). Amy M. Kilbourne, Ph.D., M.P.H., and Tami L. Mark, Ph.D., are editors of this column.
Reference

1 Healthcare Effectiveness Data and Information Set 2009: Technical Specifications, vol 2. Washington, DC, National Committee for Quality Assurance, 2008Google Scholar